Natacha Beaumont

Building Sustainable Family Businesses and Capital Entrepreneurship - SDG, Design & Science/Tech - Locally Anchored, Globally Connected.

📍 Ghent Metropolitan Area, Belgium🔄 Updated September 2026💼 8 investments📅 15 years investing🗓 Last invested Jun 2018
VC🌍 Belgium
8
Total investments
1
Early stage
1
Mid stage
0
Late stage
15y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jul 2014
The label was born in 2010 and is the brainchild of Myriam Ullens. An elitist with a sharp, pragmatic mind, she conveys her values, her cultural and charitable commitments and entrepreneurial acumen while scoffing at time zones and cementing her vision of a ready-to-travel luxury label that has its sights sets on out-of-the-ordinary “citizens of the world”. She has named the creative Veronique Leroy as artistic director. Both women share the same quest for excellence and a powerful complicity open to kindness and respect.
Board Member
Dec 2011
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of cancer immunology and immunosuppressive pathways to design novel product candidates with the potential to fully restore the immune response against cancer. The Company’s innovative pipeline includes two clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes. The first antibody product candidate, EOS-448, is a high affinity, potent, anti-TIGIT antibody with a functional Fc domain, designed to enhance the anti-tumor response through a multifaceted immune modulatory mechanism, currently progressing in multiple indications in collaboration with GSK. The Company is also advancing inupadenant, a next-generation adenosine A2A receptor antagonist tailored to overcome cancer immunosuppression into proof-of concept trials in several indications following encouraging single-agent activity in Phase 1. iTeos Therapeutics is headquartered in Cambridge, MA with a research center in Gosselies, Belgium.
Experience · 16 entries
All (16)
Investments (8)
Founder (2)
Board (7)
2023
Business Partner
Oct 2023
Consilio Partners begeleidt bedrijven in transitie en bij belangrijke kantelmomenten. Daarbij wordt rekening gehouden met de specifieke perspectieven van de aandeelhouders, de bestuurders en het management, en met het unieke karakter en de eigen cultuur van elk bedrijf. Dankzij een multidisciplinaire aanpak en geïntegreerde methodiek zijn we in staat om gerichte oplossingen te bieden. In dat kader betekent de recente uitbreiding van het Consilio Partners team een belangrijke stap in de verruiming en versterking van ons dienstenaanbod. Bedrijven in verandering worden vaak geconfronteerd met ongeziene uitdagingen die leiden tot onzekerheid, spanning en zelfs conflict. Veelal zet dit de dynamiek bij en tussen aandeelhouders, raad van bestuur en het management onder druk en zijn ingrijpende maatregelen nodig. Vanwege de uitgebreide deskundigheid van onze partners zijn we goed geplaatst om als klankbord op te treden, inzicht te verschaffen en bruggen te slaan, en zo oplossingen aan te reiken en actief mee te werken aan een concreet plan van aanpak. De unieke complementariteit van ervaring en expertise tussen de Consilio partners laat toe om op vele vlakken raad te verlenen en antwoorden te bieden, gaande van deugdelijk bestuur en strategisch beleid tot operationele uitvoering en functionele ondersteuning op vlak van financieel advies en beheer, leiderschaps- en organizatieontwikkeling en begeleiding bij opvolging en generatiewisseling. Onze kracht zit in ons vermogen om in te spelen op de specifieke karakteristieken van een probleemsituatie of uitdaging, zowel op het niveau van de aandeelhouders als in samenspraak met de Raad van Bestuur en de voorzitter, of de CEO en het management team.
Business Partner
Oct 2023
Axxess Partners is an independent entrepreneurial corporate finance boutique. The firm has an international track record of two billion Euros of accomplished cross-border transactions in a wide range of different industries.
2018
Family Office Circle Foundation
Member of the Board
Jun 2018
Family Office Circle Foundation
Member of the Board
Jun 2018
2017
Board Observer
Jul 2017
Sinequa’s Search Cloud brings organizations of all sizes the most complete enterprise search ever. Customers employ Search Cloud to connect all content (both text and data), derive meaning, learn from user interactions, and present information in context. This solves content chaos and informs employees through a single, secure interface. They get the knowledge, expertise, and insights needed to make informed decisions and do more, faster. Sinequa helps these organizations accelerate innovation, reduce rework, foster collaboration, ensure compliance, and increase productivity. For more information visit www.sinequa.com.
Show all 16 entries ↓
Investment activity
2011–2018 · 8 investments
201112012220141201612017120182
Recent (last 2 years)Earlier